Keyword Search Year None 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Sep 10, 2026 Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day Read more » Sep 08, 2026 Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials Read more » Aug 31, 2026 Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Read more » Aug 28, 2026 Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference Read more » Aug 24, 2026 Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings Read more » Aug 18, 2026 Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health Read more » Aug 17, 2026 Labcorp to Host Investor Day on September 10, 2026 Read more » Aug 10, 2026 Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma Read more » Aug 04, 2026 Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer Read more » Jul 30, 2026 Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance Read more » Jul 27, 2026 Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing Read more » Jul 09, 2026 Labcorp Declares Quarterly Dividend Read more » Jun 30, 2026 Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 Read more » Jun 22, 2026 Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test Read more » May 29, 2026 Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer Read more » May 28, 2026 Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects Read more » May 27, 2026 Labcorp to Present at the Jefferies Global Healthcare Conference Read more » May 20, 2026 Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time Read more » May 12, 2026 Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems Read more » May 07, 2026 Labcorp Publishes 2025 Corporate Responsibility Report, Highlighting Progress in Sustainability, Access to Care and Employee Well-Being Read more » Apr 30, 2026 Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance Read more » Apr 22, 2026 Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA® Read more » Apr 15, 2026 Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes Read more » Apr 14, 2026 Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research Read more » Apr 13, 2026 Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide Read more » Current page 1 Page 2 Next page next › Last page last »
